These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A. Kumar P; Gao K; Wang C; Pivetti C; Lankford L; Farmer D; Wang A Cell Transplant; 2018 Jan; 27(1):130-139. PubMed ID: 29562772 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs. Son JS; Park CY; Lee G; Park JY; Kim HJ; Kim G; Chi KY; Woo DH; Han C; Kim SK; Park HJ; Kim DW; Kim JH Biomaterials; 2022 Apr; 283():121429. PubMed ID: 35217482 [TBL] [Abstract][Full Text] [Related]
24. Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A. Gong J; Yang R; Zhou M; Chang LJ Mol Med; 2023 Jun; 29(1):74. PubMed ID: 37308845 [TBL] [Abstract][Full Text] [Related]
25. Clinical manifestation of hemophilia A in the absence of mutations in the F8 gene that encodes FVIII: role of microRNAs. Jankowska KI; McGill J; Pezeshkpoor B; Oldenburg J; Atreya CD; Sauna ZE Transfusion; 2020 Feb; 60(2):401-413. PubMed ID: 31785023 [TBL] [Abstract][Full Text] [Related]
26. Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9. Park CY; Sung JJ; Cho SR; Kim J; Kim DW Stem Cell Reports; 2019 Jun; 12(6):1242-1249. PubMed ID: 31105049 [TBL] [Abstract][Full Text] [Related]
27. Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A. Wang X; Shin SC; Chiang AF; Khan I; Pan D; Rawlings DJ; Miao CH Mol Ther; 2015 Apr; 23(4):617-26. PubMed ID: 25655313 [TBL] [Abstract][Full Text] [Related]
28. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523 [TBL] [Abstract][Full Text] [Related]
29. Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene. Sarachana T; Dahiya N; Simhadri VL; Pandey GS; Saini S; Guelcher C; Guerrera MF; Kimchi-Sarfaty C; Sauna ZE; Atreya CD PLoS One; 2015; 10(7):e0132433. PubMed ID: 26176629 [TBL] [Abstract][Full Text] [Related]
30. Generation of induced pluripotent stem cell GZLSL-i001-A derived from urine-derived cells of Hemophilia A patient with Inv22 mutation. Lu D; Xue Y; Song B; Liu N; Xie Y; Cheng Y; Chen B; He L; Chen D; Zeng J; Yang Y; Guo X; Li Y; Sun X Stem Cell Res; 2020 Dec; 49():102053. PubMed ID: 33212352 [TBL] [Abstract][Full Text] [Related]
31. Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From Qiu L; Xie M; Zhou M; Liu X; Hu Z; Wu L Front Cell Dev Biol; 2021; 9():630353. PubMed ID: 33644070 [TBL] [Abstract][Full Text] [Related]
32. Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy. Wang JJ; Kuang Y; Zhang LL; Shen CL; Wang L; Lu SY; Lu XB; Fei J; Gu MM; Wang ZG Genet Mol Res; 2013 May; 12(2):1511-21. PubMed ID: 23765957 [TBL] [Abstract][Full Text] [Related]
33. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Lipshutz GS; Sarkar R; Flebbe-Rehwaldt L; Kazazian H; Gaensler KM Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13324-9. PubMed ID: 10557319 [TBL] [Abstract][Full Text] [Related]
34. Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution. Guillet B; Lambert T; d'Oiron R; Proulle V; Plantier JL; Rafowicz A; Peynet J; Costa JM; Bendelac L; Laurian Y; Lavergne JM Hum Mutat; 2006 Jul; 27(7):676-85. PubMed ID: 16786531 [TBL] [Abstract][Full Text] [Related]
35. Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice. Stagaard R; Ley CD; Almholt K; Olsen LH; Knudsen T; Flick MJ Blood Adv; 2018 Nov; 2(22):3126-3136. PubMed ID: 30459211 [TBL] [Abstract][Full Text] [Related]
36. The mesenchymal stem cells derived from transgenic mice carrying human coagulation factor VIII can correct phenotype in hemophilia A mice. Wang Q; Gong X; Gong Z; Ren X; Ren Z; Huang S; Zeng Y J Genet Genomics; 2013 Dec; 40(12):617-28. PubMed ID: 24377868 [TBL] [Abstract][Full Text] [Related]
37. The F8(-/-) rat as a model of hemophilic arthropathy. Sørensen KR; Roepstorff K; Wiinberg B; Hansen AK; Tranholm M; Nielsen LN; Kjelgaard-Hansen M J Thromb Haemost; 2016 Jun; 14(6):1216-25. PubMed ID: 27060449 [TBL] [Abstract][Full Text] [Related]
38. A Foundational Study for Normal Jankowska KI; Chattopadhyay M; Sauna ZE; Atreya CD Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781510 [TBL] [Abstract][Full Text] [Related]
39. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes. Andrews JL; Weaver L; Kaleko M; Connelly S Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282 [TBL] [Abstract][Full Text] [Related]
40. Characterization of four novel molecular changes in the promoter region of the factor VIII gene. Nougier C; Roualdes O; Fretigny M; d'Oiron R; Costa C; Negrier C; Vinciguerra C Haemophilia; 2014 Mar; 20(2):e149-56. PubMed ID: 24372689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]